These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Analysis of Heart Rate Variability and Cardiac Autonomic Nerve Remodeling in Streptozotocin-induced Diabetic Rats. Li X; Jiang YH; Jiang P; Lin HQ; Yang JL; Ma DF; Wang X; Yang CH Exp Clin Endocrinol Diabetes; 2015 May; 123(5):272-81. PubMed ID: 25962404 [TBL] [Abstract][Full Text] [Related]
23. NGF protects paravertebral but not prevertebral sympathetic neurons against exposure to high glucose in vitro. Semra YK; Sherif S; Lincoln J Brain Res; 2009 Aug; 1285():164-73. PubMed ID: 19505442 [TBL] [Abstract][Full Text] [Related]
24. Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TrkA content of prevertebral and paravertebral rat sympathetic ganglia. Schmidt RE; Dorsey DA; Roth KA; Parvin CA; Hounsom L; Tomlinson DR Brain Res; 2000 Jun; 867(1-2):149-56. PubMed ID: 10837808 [TBL] [Abstract][Full Text] [Related]
25. Effect of IGF-I and neurotrophin-3 on gracile neuroaxonal dystrophy in diabetic and aging rats. Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Parvin CA; Ohara S Brain Res; 2000 Sep; 876(1-2):88-94. PubMed ID: 10973596 [TBL] [Abstract][Full Text] [Related]
26. The effect of pancreatic islet transplantation and insulin therapy on neuroaxonal dystrophy in sympathetic autonomic ganglia of chronic streptozocin-diabetic rats. Schmidt RE; Plurad SB; Olack BJ; Scharp DW Brain Res; 1989 Sep; 497(2):393-8. PubMed ID: 2510903 [TBL] [Abstract][Full Text] [Related]
27. Effects of sorbinil, dietary myo-inositol supplementation, and insulin on resolution of neuroaxonal dystrophy in mesenteric nerves of streptozocin-induced diabetic rats. Schmidt RE; Plurad SB; Coleman BD; Williamson JR; Tilton RG Diabetes; 1991 May; 40(5):574-82. PubMed ID: 1902427 [TBL] [Abstract][Full Text] [Related]
28. Tyrosine hydroxylase activity in sympathetic nervous system of rats with streptozocin-induced diabetes. Schmidt RE; Cogswell BE Diabetes; 1989 Aug; 38(8):959-68. PubMed ID: 2568957 [TBL] [Abstract][Full Text] [Related]
29. Neuropathology and pathogenesis of diabetic autonomic neuropathy. Schmidt RE Int Rev Neurobiol; 2002; 50():257-92. PubMed ID: 12198813 [TBL] [Abstract][Full Text] [Related]
30. Neuritic dystrophy and neuronopathy in Akita (Ins2(Akita)) diabetic mouse sympathetic ganglia. Schmidt RE; Green KG; Snipes LL; Feng D Exp Neurol; 2009 Mar; 216(1):207-18. PubMed ID: 19111542 [TBL] [Abstract][Full Text] [Related]
31. Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2 Akita) diabetic mouse sympathetic ganglia. Schmidt RE; Feng D; Wang Q; Green KG; Snipes LL; Yamin M; Brines M Exp Neurol; 2011 Dec; 232(2):126-35. PubMed ID: 21872588 [TBL] [Abstract][Full Text] [Related]
32. Neuronal preservation in the sympathetic ganglia of rats with chronic streptozotocin-induced diabetes. Schmidt RE Brain Res; 2001 Dec; 921(1-2):256-9. PubMed ID: 11720733 [TBL] [Abstract][Full Text] [Related]
33. Effect of diabetes and aging on human sympathetic autonomic ganglia. Schmidt RE; Plurad SB; Parvin CA; Roth KA Am J Pathol; 1993 Jul; 143(1):143-53. PubMed ID: 8317545 [TBL] [Abstract][Full Text] [Related]
34. Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy. Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Williamson JR; Ido Y J Neuropathol Exp Neurol; 1998 Dec; 57(12):1175-89. PubMed ID: 9862641 [TBL] [Abstract][Full Text] [Related]
35. Differential effect of chronic vitamin E deficiency on the development of neuroaxonal dystrophy in rat gracile/cuneate nuclei and prevertebral sympathetic ganglia. Schmidt RE; Coleman BD; Nelson JS Neurosci Lett; 1991 Feb; 123(1):102-6. PubMed ID: 2062445 [TBL] [Abstract][Full Text] [Related]
36. The role of impaired insulin/IGF action in primary diabetic encephalopathy. Li ZG; Zhang W; Sima AA Brain Res; 2005 Mar; 1037(1-2):12-24. PubMed ID: 15777748 [TBL] [Abstract][Full Text] [Related]
37. Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide. Sima AA; Zhang W; Li ZG; Murakawa Y; Pierson CR Diabetes; 2004 Jun; 53(6):1556-63. PubMed ID: 15161761 [TBL] [Abstract][Full Text] [Related]
38. A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats. Sima AA; Zhang W; Xu G; Sugimoto K; Guberski D; Yorek MA Diabetologia; 2000 Jun; 43(6):786-93. PubMed ID: 10907124 [TBL] [Abstract][Full Text] [Related]
39. Neuroaxonal dystrophy in aging human sympathetic ganglia. Schmidt RE; Chae HY; Parvin CA; Roth KA Am J Pathol; 1990 Jun; 136(6):1327-38. PubMed ID: 1694057 [TBL] [Abstract][Full Text] [Related]
40. Retrograde axonal transport of intravenously administered 125I-nerve growth factor in rats with streptozotocin-induced diabetes. Schmidt RE; Modert CW; Yip HK; Johnson EM Diabetes; 1983 Jul; 32(7):654-63. PubMed ID: 6345245 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]